Related Experiment Videos
Hepatic amoebiasis in immunodepressed mice.
Summary
Immunodepression in mice infected with Entamoeba histolytica increased the risk of hepatic lesions. This study highlights the impact of immune status on amoebic disease severity and progression.
Area of Science:
- Immunology
- Parasitology
- Hepatology
Background:
- Entamoeba histolytica is a protozoan parasite that causes amoebiasis, a significant global health concern.
- Intestinal and hepatic amoebiasis are serious manifestations of E. histolytica infection.
- The role of the host immune system in modulating amoebiasis severity is not fully understood.
Purpose of the Study:
- To investigate the impact of immunodepression on the development of intestinal and hepatic lesions caused by Entamoeba histolytica.
- To compare the effects of different immunodepressive agents on amoebiasis.
- To analyze the histological characteristics of lesions in immunodepressed mice.
Main Methods:
- Inbred C3H/mg mice were used to study amoebic lesions.
- Immunodepression was induced using cyclophosphamide or anti-mouse lymphocyte serum.
- Macroscopic and microscopic examination of intestinal and hepatic tissues was performed.
Main Results:
- Immunodepression did not alter the degree of macroscopic intestinal damage.
- Mice treated with anti-mouse lymphocyte serum exhibited hepatic lesions.
- Histological analysis revealed that these hepatic lesions closely resembled human and hamster hepatic amoebiasis.
Conclusions:
- Immunodepression, particularly with anti-mouse lymphocyte serum, exacerbates Entamoeba histolytica infection by promoting hepatic lesion development.
- The observed histological similarities suggest a conserved pathological mechanism in hepatic amoebiasis across species.
- These findings underscore the critical role of immune status in the pathogenesis of invasive amoebiasis.